In breast cancer, the role of IL‐22 has been shown in stimulating epithelial cell proliferation, transformation, and migration (Kim et al., 2014; Rui et al., 2017; Voigt et al., 2017; Wang et al., 2018). The gene discussed is IL22; the disease is breast carcinoma.